The regulatory molecular mechanism of the NRF2/KEAP1 pathway against metabolic reprogramming in cancer has been recently reviewed [114,115], suggesting that regulation of the NRF2/KEAP1 axis might serve as a novel therapeutic strategy for cancer. Here, KEAP1 is linked to cancer.